Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Maytenus Senegalensis for Uncomplicated Malaria
NCT04944966Phase 2Completed
- Sponsor
- Ifakara Health Institute
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Modality
- Herbal Medicine
- Countries
- 1
01
Overview
A Phase 2 trial of maytenus senegalensis in malaria, sponsored by Ifakara Health Institute. Started Jun 2021; status: completed.
02
Drugs
maytenus senegalensis
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04944966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04944966.